Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;9(5):126.
doi: 10.3390/geriatrics9050126.

Missed Insights for Earlier Management of Parkinson's Disease and the Value of Dopamine Transporter (DAT) Scans

Affiliations

Missed Insights for Earlier Management of Parkinson's Disease and the Value of Dopamine Transporter (DAT) Scans

Mohib Hafeez et al. Geriatrics (Basel). .

Abstract

Background/Objectives: This retrospective study focused on the role of Dopamine Transporter (DAT) scans in diagnosing Parkinson's Disease (PD) in older adults with cognitive impairment (CI). Methods: We retrospectively analyzed brain imaging of 6483 individuals aged 60 and above with CI. Among these, 297 underwent a DAT scan, with 189 testing positive and 89 starting dopamine therapy. In contrast, 173 patients exhibited PD-associated structural changes on CT or MRI without receiving DAT scans or treatment. Results: Of these patients, 50 (29%) experienced falls. This points towards a potential missed diagnosis of PD, which can respond to therapy in the early stages. Conclusions: Our results suggest that providers may overlook subtle signs of parkinsonism in patients with CI, resulting in symptoms worsening and treatment delay. Since CI is often first brought to the attention of PCPs, our findings call for an increased effort to inform PCPs of the role of DAT scans in aiding the diagnosis of dopamine deficiency states. By understanding PD-related structural changes seen on brain imaging and using a DAT scan to confirm dopamine deficiency, treatment for PD or related states might be started earlier or a timely referral made to a specialist, reducing patient disability and improving their quality of life.

Keywords: Parkinson’s disease; cognitive impairment; dopamine transporter scan; early diagnosis; falls; geriatric neurology; neuroimaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Showcases the difference in the number of patients who experienced falls between the DAT+ and the Missed Diagnosis groups. The significant increase in the percentage of falls could potentially be attributed to unmanaged Parkinsonian symptoms due to a lack of dopamine optimization therapy in the Missed Diagnosis group in comparison to the DAT+ group.
Figure 2
Figure 2
To navigate and view the multimorbidities present in the Missed Diagnosis group, an upset plot was generated to view and quantify the presence of other etiological causes of symptoms.
Figure 3
Figure 3
This violin plot illustrates the age distribution of patients in the DAT+ and Missed Diagnosis groups. The width of each violin represents the density of patients at different ages within each group. The plot highlights the spread and central tendency of ages, providing a demographic visual for the two groups.

Similar articles

References

    1. Kouli A., Torsney K.M., Kuan W.L. Parkinson’s Disease: Pathogenesis and Clinical Aspects. Exon Publications; Brisbane, Australia: 2018. Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. - DOI
    1. Alster P. Significance of Dysautonomia in Parkinson’s Disease and Atypical Parkinsonisms. Neurol. Neurochir. Pol. 2024;58:147–149. doi: 10.5603/pjnns.98678. - DOI - PubMed
    1. Colosimo C., Prange S., Ebke M., Antonini A., Poewe W. Differentiation of Atypical Parkinson Syndromes. J. Neural Transm. 2017;124:997–1004. doi: 10.1007/s00702-017-1700-4. - DOI - PubMed
    1. Tysnes O.B., Storstein A. Epidemiology of Parkinson’s disease. J. Neural Transm. 2017;124:901–905. doi: 10.1007/s00702-017-1686-y. - DOI - PubMed
    1. Kägi G., Bhatia K.P., Tolosa E. The role of DAT-SPECT in movement disorders. J. Neurol. Neurosurg. Psychiatry. 2010;81:5–12. doi: 10.1136/jnnp.2008.157370. - DOI - PubMed

LinkOut - more resources